Adam R. Craig
Executive Chairman, Director · X4 Pharmaceuticals, Inc
- 2025
- Aug 13, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Adam R. Craig files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Kirske - $143K in XFOR purchases and sales in the last 12 months
- John Volpone - $109K in XFOR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Adam R. Craig?
Adam R. Craig is a corporate insider, tracked as Executive Chairman, Director of X4 Pharmaceuticals, Inc (XFOR). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Adam R. Craig submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Adam R. Craig been buying or selling stock?
Recorded transactions: 1 open-market purchase ($250K) and 1 open-market sale ($211K) across all tracked filings.
